Ampicillin and Sulbactam Injection
Ampicillin and sulbactam injection is a combination antibiotic used to treat bacterial infections of the skin, abdomen, and female reproductive tract.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 28 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Ampicillin and Sulbactam Injection: Patient Information Guide
A plain-language walkthrough of Ampicillin and Sulbactam Injection — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Ampicillin and sulbactam injection treats bacterial infections caused by organisms that are susceptible to this antibiotic combination, including bacteria that produce enzymes (beta-lactamases) to resist standard penicillins.
- Skin and skin structure infections — caused by resistant strains of bacteria including Staphylococcus aureus, Escherichia coli, Klebsiella species, Proteus mirabilis, Bacteroides fragilis, Enterobacter species, and Acinetobacter calcoaceticus
- Intra-abdominal infections — caused by resistant E. coli, Klebsiella species, Bacteroides species (including B. fragilis), and Enterobacter species
- Gynecological infections — caused by resistant E. coli and Bacteroides species (including B. fragilis)
- Mixed infections involving both ampicillin-susceptible organisms and resistant bacteria may be treated with this combination without adding a second antibiotic
- For pediatric patients aged 1 year and older, Unasyn is given by intravenous infusion for these same types of infections; the IM route is not established in children
⚙️How it works▾
Ampicillin kills bacteria by interfering with the construction of their cell wall — a structure the bacteria need to survive. Without an intact wall, the bacteria break apart and die. Sulbactam doesn't do much killing on its own, but it plays a critical support role: it permanently disables beta-lactamases, the enzymes some bacteria produce to destroy ampicillin. By blocking those enzymes, sulbactam allows ampicillin to work against bacteria that would otherwise be resistant to it.
This combination gives the antibiotic a much broader reach — covering many gram-positive and gram-negative bacteria, including strains resistant to standard penicillins and cephalosporins.
💊How it's taken▾
Ampicillin and sulbactam injection is always given by a healthcare professional — never at home. It is administered either into a vein (IV) or into a muscle (IM) in adults.
- It is typically given every 6 hours, though kidney problems may require less frequent dosing (every 8, 12, or 24 hours)
- IV doses can be given as a slow injection or as a longer infusion, depending on the clinical situation
- In pediatric patients 1 year or older, it is given only by IV infusion, in divided doses every 6 hours; IV treatment in children should generally not exceed 14 days
- Children weighing 40 kg or more are dosed like adults
Always follow your prescriber's exact instructions. Do not adjust the schedule without checking with your care team first.
🤒Side effects — in detail▾
Most people tolerate ampicillin and sulbactam injection well. The most commonly reported side effects include:
- Pain at the injection site (more common with IM injection)
- Diarrhea
- Rash
- Nausea or vomiting
- Itching
- Headache
- Vein irritation or inflammation (thrombophlebitis) at the IV site
- Fatigue or feeling unwell
More serious reactions — including severe allergic reactions, life-threatening skin conditions, liver problems, and C. difficile diarrhea — can occur and require immediate medical attention. Tell your care team about any new symptoms right away.
⚠️Warnings & precautions▾
- Severe allergic reactions: Life-threatening anaphylaxis (a sudden, whole-body allergic reaction) has been reported. People with a history of penicillin or cephalosporin allergy are at higher risk. Emergency treatment must be available.
- Serious skin reactions: Rare but potentially fatal skin conditions including Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), and DRESS syndrome have occurred. Any new rash during treatment must be evaluated promptly — if it progresses, the drug must be stopped.
- Liver toxicity: Hepatitis and cholestatic jaundice (liver inflammation that impairs bile flow) have been reported, rarely with fatal outcomes. Patients with liver disease should have their liver function monitored regularly during treatment.
- Clostridioides difficile (C. difficile) infection: Like all antibiotics, this medication can disrupt normal gut bacteria and allow C. difficile to overgrow, causing severe diarrhea or colitis. This can occur during treatment or up to two months afterward.
- Antibiotic resistance: This medication should only be used for proven or strongly suspected bacterial infections to help prevent the development of resistant bacteria.
🔀What it interacts with▾
Ampicillin and sulbactam injection can interact with a few other medications. Be sure your care team knows everything you take:
- Probenecid (used for gout) — slows the kidneys' removal of ampicillin and sulbactam, increasing and prolonging blood levels of both drugs
- Allopurinol (used for gout or high uric acid) — substantially increases the risk of developing a skin rash when taken at the same time as ampicillin
- Aminoglycoside antibiotics (such as gentamicin or tobramycin) — must never be mixed in the same IV bag or syringe as ampicillin and sulbactam, because the ampicillin component can inactivate the aminoglycoside
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use this medication if you have ever had a serious allergic reaction — such as anaphylaxis or Stevens-Johnson syndrome — to penicillins, cephalosporins, or other beta-lactam antibiotics
- Do not use this medication if you have previously developed jaundice or liver problems specifically linked to ampicillin and sulbactam
- Tell your doctor about any past antibiotic allergies or reactions to multiple allergens before starting treatment
- Tell your doctor if you have kidney disease — the dosing schedule will need to be adjusted based on how well your kidneys work
- Tell your doctor if you have liver disease — liver function should be checked regularly during treatment
- Tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding
- In children aged 1 year and older, the IV route is used; the IM route has not been shown to be safe and effective in pediatric patients
🚑If you take too much▾
Taking too much of this medication can cause neurological side effects, including seizures (convulsions), especially if high levels build up in the fluid around the brain and spinal cord. If an overdose is suspected, seek emergency medical care immediately. The label notes that ampicillin — and likely sulbactam — can be partially removed from the blood by hemodialysis (a kidney-filtering procedure).
📡Pharmacodynamics — effects in the body▾
Ampicillin and sulbactam injection works by killing susceptible bacteria during their active growth phase — it disrupts the construction of the bacterial cell wall, which is essential for bacterial survival. Sulbactam permanently disables the beta-lactamase enzymes that would otherwise break down ampicillin, extending the antibiotic's reach to bacteria that carry resistance. The result is a broad-spectrum antibacterial effect covering many gram-positive and gram-negative bacteria, including resistant strains.
🔬Pharmacokinetics — how your body processes it▾
When given as a 15-minute IV infusion, peak blood levels of both ampicillin and sulbactam are reached immediately after the infusion is complete. After an IM injection, drug levels in the blood are lower but still therapeutic. Both drugs have a short half-life of about 1 hour in people with normal kidney function, meaning they are cleared fairly quickly. Approximately 75–85% of both drugs are eliminated unchanged through the urine within the first 8 hours, so kidney function has a direct impact on how long the drugs stay in the body and how often they need to be given.
📦How to store it▾
stored at 20° to 25°C (68° to 77°F) prior to reconstitution.
📄 Written from Ampicillin and Sulbactam Injection’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Ampicillin and Sulbactam Injection — the kind of thing our pharmacy team would talk through with you at the counter.
What kinds of infections does this antibiotic treat? ▾
Why does this antibiotic have two drugs in it? ▾
What side effects should I watch out for while I'm getting this? ▾
I've had a penicillin allergy before. Is this safe for me? ▾
I'm also taking allopurinol for gout. Is that a problem? ▾
I have kidney disease — does that affect how I get this antibiotic? ▾
Is Ampicillin and Sulbactam Injection available over the counter? ▾
When was Ampicillin and Sulbactam Injection first available? ▾
Who makes Ampicillin and Sulbactam Injection? ▾
💬 Answers drafted from Ampicillin and Sulbactam Injection’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Ampicillin and Sulbactam Injection comes
Ampicillin and Sulbactam Injection is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Injection
How this form is used
- Unasyn treats skin and skin structure infections caused by resistant bacteria including Staphylococcus aureus, E. coli, and Klebsiella
- Unasyn treats intra-abdominal infections caused by bacteria such as E. coli, Klebsiella, Bacteroides, and Enterobacter
- Unasyn treats gynecological infections caused by E. coli and Bacteroides species
- Unasyn can be given into a vein (IV) as a slow injection over at least 10–15 minutes, or as a longer infusion over 15–30 minutes
- Unasyn can also be given by deep intramuscular (IM) injection in adults; however, the IM route has not been established for pediatric patients
- In pediatric patients 1 year of age or older, Unasyn is given by intravenous infusion in divided doses every 6 hours; IV treatment generally should not exceed 14 days
- Patients with kidney impairment may receive Unasyn less frequently — dosing intervals are adjusted based on kidney function
Show 12 more strengths Show fewer strengths
📊 Ampicillin and Sulbactam Injection across the U.S. market
How Ampicillin and Sulbactam Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (4) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Ampicillin and Sulbactam Injection is used
A general measure of how commonly Ampicillin and Sulbactam Injection is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Ampicillin and Sulbactam Injection is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Ampicillin and Sulbactam Injection prescribed? Of the 1,597 medications we measure, Ampicillin and Sulbactam Injection ranks #758 by Medicaid prescriptions — more than 53% of them.
Utilization by Ampicillin and Sulbactam Injection product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
ampicillin 2000 MG / sulbactam 1000 MG Injection Most dispensed
Summed across the 12 of 44 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1659598
ampicillin 100 MG/ML / sulbactam 50 MG/ML Injectable Solution
Summed across the 7 of 23 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 240984
ampicillin 1000 MG / sulbactam 500 MG Injection
Summed across the 5 of 40 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1659592
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Ampicillin and Sulbactam Injection, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 24 of 107 listed Ampicillin and Sulbactam Injection NDCs with Medicaid activity.
🔍 Compare Ampicillin and Sulbactam Injection products
A representative set of FDA-listed product records for Ampicillin and Sulbactam Injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| AMPICILLIN SODIUM 10 g/15 g; SULBACTAM SODIUM 5 g/15 g | Intramuscular, Intravenous | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | Avenacy, LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | Avenacy, LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g | Intravenous | Avenacy, LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | Civica, Inc. | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Civica, Inc. × 2 listings | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Civica, Inc. × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 100 mg/mL; SULBACTAM SODIUM 50 mg/mL | Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intravenous | Eugia US LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intravenous | Eugia US LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Eugia US LLC × 3 listings | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Eugia US LLC × 3 listings | ANDA | View NDC → |
| 2; 1 g/1; g | Intravenous | Eugia US LLC × 2 listings | ANDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intravenous | Eugia US LLC × 3 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 100 mg/mL; SULBACTAM SODIUM 50 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1.5 g; SULBACTAM SODIUM 0.5 g/1.5 g | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/3 g; SULBACTAM SODIUM 1 g/3 g | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 1; 0.5 g/1.5 g; g/1.5 g | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 2; 1 g/3 g; g/3 g | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 250; 125 mg/mL; mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intravenous | Hospira, Inc | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intravenous | Hospira, Inc | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intravenous | Hospira, Inc × 2 listings | ANDA | View NDC → |
| 2; 1 g/1; g | Intravenous | Hospira, Inc × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | Medical Purchasing Solutions, LLC. | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | Meitheal Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | Meitheal Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g | Intravenous | Meitheal Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Meitheal Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Meitheal Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 10; 5 g/1; g | Intravenous | Meitheal Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Methapharm, Inc. | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Methapharm, Inc. | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Mylan Institutional LLC | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Mylan Institutional LLC × 2 listings | ANDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intramuscular; Intravenous | Mylan Institutional LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | NorthStar Rx, LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | NorthStar Rx, LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g | Intramuscular, Intravenous | NorthStar Rx, LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | Onesource Specialty Pharma Limited | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | Onesource Specialty Pharma Limited | ANDA | View NDC → |
| AMPICILLIN SODIUM 10 g/15 g; SULBACTAM SODIUM 5 g/15 g | Intramuscular, Intravenous | Onesource Specialty Pharma Limited | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Piramal Critical Care Inc × 2 listings | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Piramal Critical Care Inc × 2 listings | ANDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intravenous | Piramal Critical Care Inc | ANDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intramuscular; Intravenous | Piramal Critical Care Inc | ANDA | View NDC → |
| AMPICILLIN SODIUM 100 mg/mL; SULBACTAM SODIUM 50 mg/mL | Intramuscular, Intravenous | Roerig × 2 listings | NDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | Roerig × 2 listings | NDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | Roerig × 2 listings | NDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Roerig × 2 listings | NDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Roerig × 2 listings | NDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intramuscular; Intravenous | Roerig × 2 listings | NDA | View NDC → |
| AMPICILLIN SODIUM 100 mg/mL; SULBACTAM SODIUM 50 mg/mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | Sagent Pharmaceuticals × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g | Intramuscular, Intravenous | Sagent Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Steriscience Specialties Private Limited | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Steriscience Specialties Private Limited | ANDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intravenous | West-Ward Pharmaceuticals Corp. | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/1; SULBACTAM SODIUM 0.5 g | Intramuscular, Intravenous | WG Critical Care, LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 1 g/10 mL; SULBACTAM SODIUM 0.5 g/10 mL | Intramuscular, Intravenous | WG Critical Care, LLC | ANDA | View NDC → |
| SULBACTAM SODIUM 1 g/1; AMPICILLIN SODIUM 2 g | Intramuscular, Intravenous | WG Critical Care, LLC × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 2 g/20 mL; SULBACTAM SODIUM 1 g/20 mL | Intramuscular, Intravenous | WG Critical Care, LLC × 2 listings | ANDA | View NDC → |
| AMPICILLIN SODIUM 10 g/1; SULBACTAM SODIUM 5 g | Intravenous | WG Critical Care, LLC | ANDA | View NDC → |
| AMPICILLIN SODIUM 10 g/100 mL; SULBACTAM SODIUM 5 g/100 mL | Intravenous | WG Critical Care, LLC | ANDA | View NDC → |
| 1; 0.5 g/10 mL; g/10 mL | Intramuscular; Intravenous | WG Critical Care, LLC | ANDA | View NDC → |
| 1; 0.5 g/20 mL; g/20 mL | Intramuscular; Intravenous | WG Critical Care, LLC | ANDA | View NDC → |
| 2; 1 g/20 mL; g/20 mL | Intramuscular; Intravenous | WG Critical Care, LLC × 3 listings | ANDA | View NDC → |
| 10; 5 g/100 mL; g/100 mL | Intravenous | WG Critical Care, LLC | ANDA | View NDC → |
| 1; 0.5 g/1; g | Intramuscular; Intravenous | Xellia Pharmaceuticals USA LLC × 2 listings | ANDA | View NDC → |
| 2; 1 g/1; g | Intramuscular; Intravenous | Xellia Pharmaceuticals USA LLC × 2 listings | ANDA | View NDC → |
| 100; 50 mg/mL; mg/mL | Intramuscular; Intravenous | Xellia Pharmaceuticals USA LLC × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| AMPICILLIN SODIUM 1 kg/kg; SULBACTAM SODIUM 1 kg/kg | — | ACS Dobfar S.p.A | DRUG FOR FURTHER PROCESSING | View NDC → |
| AMPICILLIN SODIUM 33.25 kg/50 kg; SULBACTAM SODIUM 16.75 kg/50 kg | — | Aurobindo Pharma Limited | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| SULBACTAM SODIUM 66.67 kg/100 kg; AMPICILLIN SODIUM 33.3 kg/100 kg | — | Eumedica Pharmaceuticals Industries Sociedad Limitada | DRUG FOR FURTHER PROCESSING | View NDC → |
| AMPICILLIN SODIUM 5.28 kg/8 kg; SULBACTAM SODIUM 2.72 kg/8 kg | — | Fresenius Kabi iPSUM S.r.l. | DRUG FOR FURTHER PROCESSING | View NDC → |
Showing 137 of 137 products — FDA National Drug Code Directory. See every product, package size and price: browse all 137 Ampicillin and Sulbactam Injection NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Ampicillin and Sulbactam Injection — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Ampicillin and Sulbactam Injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Ampicillin and Sulbactam Injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
📦 Supply & shortage status
Whether Ampicillin and Sulbactam Injection is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Ampicillin and Sulbactam Injection belongs to the beta Lactamase Inhibitor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 28 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Roerig is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.